与甲基相关的胃潰瘍穿孔:日益令人擔憂的醫學問題
Bilal Turan1, Hakan Eroğlu1, Bülent Sultanoğlu1
1General Surgery Clinic, Dr Ersin Arslan Training and Research Hospital, Gaziantep-Türkiye.
概括
吸入甲基胺的使用与 perforation 的更高风险有关,特别是在年轻人中. 这项研究强调了这种物质与胃肠道并发症之间日益增长的联系.
科学领域:
- 胃肠病学 胃肠病学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 有限的研究存在于与吸入甲基胺使用相关的穿孔.
- 在临床上观察到穿孔性胃的增加与甲基胺消费的增加有关.
- 这项研究调查了吸入甲基胺 ("火和冰") 和胃孔穿孔之间的联系.
研究的目的:
- 为了确定吸入甲基胺的使用是否是肠道穿孔及其并发症的直接因素.
- 为了确定与甲基胺使用相关的胃潰瘍穿孔患者的人口统计变量.
主要方法:
- 对2021年手术治疗的29名胃穿孔患者的回顾性分析.
- 使用SPSS进行统计评估,包括Kolmogorov-Smirnov,Levene,t测试,Mann-Whitney U和Chi-square测试.
- 数据分析的重点是比较甲基胺使用者 (n=13) 和非使用者 (n=16).
主要成果:
- 甲基胺使用者明显年轻 (P=0.025) 并且有不同的胃潰瘍 (PU) 病史 (P=0.009).
- 在物质使用者 (P=0.020) 中,观察到较低的阿斯巴酸氨酸酶,氨酸氨基转移酶值.
- 在小组之间观察到穿孔局部的显著差异 (P<0.001);性别或临床表现没有显著差异.
结论:
- 吸入甲胺的使用是肝发育和穿孔的重要危险因素,特别是在年轻的长期使用者中.
- 这种并发症的发生率似乎正在迅速增加,正如在诊所看到的.
- 甲基胺的广泛使用构成一个重大的社会威胁,胃肠道并发症是显著的表现.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
343
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
11.9K
相关概念视频
01:30Peptic Ulcer Disease I: Introduction
176
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
176
01:26Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
434
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
434
01:22Esophageal Perforation-I: Introduction
98
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
98
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
448
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
448
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
594
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
594